Nextage Therapeutics Ltd (TLV:NXTG)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
47.00
+14.60 (45.06%)
May 20, 2026, 5:24 PM IDT
Market Cap15.84M -24.8%
Revenue (ttm)243.00K -89.1%
Net Income2.84M
EPS0.16
Shares Out33.70M
PE Ratio2.93
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume348,085
Average Volume115,931
Open39.90
Previous Close32.40
Day's Range39.90 - 48.00
52-Week Range6.20 - 107.00
Beta0.17
RSI48.19
Earnings DateMay 29, 2026

About Nextage Therapeutics

Nextage Therapeutics Ltd, a pharmaceutical company, develops cannabinoid-based products in Israel and internationally. The company was incorporated in 1982 and is based in Ness Ziona, Israel. [Read more]

Sector Healthcare
Founded 1982
Employees 31
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol NXTG
Full Company Profile

Financial Performance

In 2024, Nextage Therapeutics's revenue was 413,000, a decrease of -52.85% compared to the previous year's 876,000. Losses were -3.28 million, -15.36% less than in 2023.

Financial Statements